Search for Clinical Trial Results

Sponsored By

Hand-Foot Syndrome - 14 Studies Found

Status Study
Completed Study Name: Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
Condition:
  • Palmar-Plantar Erythrodysesthesia
  • Breast Cancer

Date: 2010-04-06
Interventions:
  • Drug: Ointment Twice daily lot
No longer available Study Name: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
Condition: the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine
Date: 2012-06-21
Interventions:
  • Device: Mapisal Mapisal®

Active, not recruiting Study Name: Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
Condition:
  • Breast Cancer
  • Chemotherapeutic Agent Toxicity
  • Date: 2008-09-10
    Interventions: Drug: nicotine Nicotine patch applied prior to and concurrently with capecitabine chemotherapy or beginn
Completed Study Name: F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer
Condition:
  • Breast Cancer
  • Palmar-plantar Erythrodysesthesia

Date: 2009-10-08
Interventions:
  • Drug: antiperspirant cream F511

Completed Study Name: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
Condition:
  • Breast Cancer
  • Colorectal Cancer
  • Palm
    Date: 2007-11-15
    Interventions:
    • Dietary Supplement: pyridoxine hydrochloride
Completed Study Name: Eniluracil Hand Foot Syndrome
Condition:
  • Breast Cancer
  • Colon Cancer

Date: 2009-01-22
Interventions:
  • Drug: Eniluracil
  • Drug: Capecitabine
Completed Study Name: Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail
Condition: Hepatocellular Carcinoma
Date: 2016-11-06
Interventions:
  • Drug: Celecoxib Patients from

Completed Study Name: A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).
Condition: Breast Cancer
Date: 2008-04-16
Interventions:
  • Drug: Corticosteroids As presc
Completed Study Name: Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)
Condition: Ovarian Neoplasms
Date: 2008-08-26
Interventions: Drug: Caelyx (Pegylated Lyposomal Doxorubicin) Pegylated Lyposomal Doxorubicin, 50 mg/m2 every 4 weeks f
Completed Study Name: Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
Condition:
  • Breast Cancer
  • Drug/Agent Toxicity by Tissue/Organ
  • Unspecif
    Date: 2006-02-23
    Interventions:
    • Dietary Supplement: pyridoxine hydrochloride

Next >>>